InsidersTradesSigma
Follow the Vistin Pharma ASA share price and the full insider trade history of the company, a listed equity based in Norway. Shares are quoted on the NO market, under the oversight of Oslo Børs. Operating in the Healthcare & Pharma sector, Vistin Pharma ASA has logged 18 reports. Market capitalisation: €909.1m. The latest transaction was reported on 20 February 2026 (Other). Among the most active insiders: Magnus Tolleshaug. Every trade is accessible without an account.
18
Insider Decl.
n/a
Thresholds
€2
1 ops.
Buy Volume
€12m
7 ops.
Sell Volume
19Σ signal
Fundamental score
Ranked 1,014 of 28,857 companies
81.0
score / 100
Value77
Quality85
FCF yld6.8%
Earn yld8.3%
EV/EBITDA7.4x
ROE22%
Gross mgn51%
Net mgn17%
Debt/EBITDA0.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 20 February 2026
Declarations18 total
30 shares@ NOK 21.100.3% of flowShareXOSLOSLO:666416
1,234,280 shares@ NOK 22.50100.0% of flowShareXOSLOSLO:645424
527,960 shares@ NOK 22.0247100.0% of flowShareXOSLOSLO:614472
@ €1.9837ShareXOSLOSLO:594694
15 shares@ NOK 24.010.2% of flowShareXOSLOSLO:592067
3,519,733 shares@ NOK 19.5081.3% of flowShareXOSLOSLO:545546
784,280 shares@ NOK 21.1018.7% of flowShareXOSLOSLO:542310
14,182 shares@ NOK 24.00100.0% of flowShareXOSLOSLO:533509
1,500,000 shares0.0% of flowShareXOSLOSLO:527782
10,000 shares@ NOK 17.3099.5% of flowShareXOSLOSLO:522056
18 of 18 declarations
About Vistin Pharma ASA
Vistin Pharma ASA is a Norwegian company focused on the development and production of pharmaceuticals for the treatment of metabolic diseases. It is listed on the Oslo Stock Exchange under the symbol XOSL.
